4-009 - Development of Pediatric Formulations of the Potassium Channel Opener Ezogabine and the NaV1.6-Selective Sodium Channel Blocker XEN901 for the Treatment of Developmental and Epileptic Encephalopathies
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: 4-009 - Development of Pediatric Formulations of the Potassium Channel Opener Ezogabine and the NaV1.6-Selective Sodium Channel Blocker XEN901 for the Treatment of Developmental and Epileptic Encephalopathies ### Output: 